David R. Ebsworth, Ph.D. (Chairman)
Formerly CEO, Oxford GlycoSciences plc
Formerly President Pharmaceutical Division, Bayer AG

Georg F. Baur, Ph.D. (Deputy Chairman)
Formerly Managing Director, JP Morgan

Professor Iris Löw-Friedrich
Executive Board member for Research and Developement SCHWARZ PHARMA AG

Alexandra Goll, Ph.D.
Partner, Techno Venture Management GmbH

Rüdiger Hauffe
Formerly CEO SmithKline Beecham GmbH

Friedrich von Bohlen und Halbach, Ph.D.
Chairman, SYGNIS Pharma AG
Managing Director Dievini advisors in health services GmbH